Distribution of the ACE Gene Polymorphisms in Type 2 Diabetes Mellitus Patients, Their Associations with Nephropathy Biomarkers and Metabolic Indicators at a Tertiary Hospital in Uganda
DOI: https://doi.org/10.2147/dmso.s462740
2024-06-05
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Ritah Kiconco, 1, 2 Robert Kalyesubula, 3, &ast Gertrude N Kiwanuka 4, &ast 1 Department of Medical Laboratory Science, Mbarara University of Science and Technology, Mbarara, Uganda; 2 Department of Biochemistry, Soroti University, Soroti, Uganda; 3 Departments of Internal Medicine and Physiology, Makerere University, Kampala, Uganda; 4 Department of Biochemistry, Mbarara University of Science and Technology, Mbarara, Uganda &astThese authors contributed equally to this work Correspondence: Ritah Kiconco, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda, Tel +256 783990501, Fax +256-485-20782, Email Purpose: We aimed at determining the distribution of the ACE insertion/deletion gene polymorphisms among type 2 diabetic patients and their association with the nephropathy biomarkers and the metabolic indicators. Patients and Methods: Data were collected from 237 adult type 2 diabetes mellitus patients receiving healthcare at the diabetic clinic of Mbarara Regional Referral Hospital. Peripheral blood genomic DNA was amplified using a conventional PCR technique and analyzed for the ACE homozygous forms of the insertion (II), deletion (DD) and heterozygous insertion deletion (ID) genotypes as well as their respective allele counts. Biomarkers of nephropathy were analyzed on a Beckman coulter AU480 chemistry analyzer using system compatible reagents. Results: Majority of the participants were older persons (Median = 57, IQR = 49– 64) and female 171 (72.2%). Most of them had the Deletion allele 198 (83.5%) and DD genotype 116 (48.9%). At multivariate logistic regression, the nephropathy biomarkers that is microalbuminuria, serum creatinine, urea, eGFR and electrolytes had no association with the ACE I/D alleles or genotypes (p > 0.05). On the other hand, selected metabolic indicators had a positive relationship. The insertion allele was associated with increasing glycated hemoglobin (OR = 1.082, p = 0.019) and decreasing serum glucose levels (OR = 0.891, p = 0.001). Deletion allele was associated with decreasing glycated hemoglobin (OR = 0.924, p = 0.047) and increasing serum glucose levels (OR = 1.208, p = 0.001). ACE II genotype was associated with decreasing serum glucose levels (OR = 0.873, p = 0.029). ACE DD genotype was associated with decreasing glycated hemoglobin (OR = 0.917, p = 0.010) and increasing serum glucose levels (OR = 1.132, p = 0.001). ACE ID genotype was associated with increasing glycated hemoglobin (OR = 1.077, p = 0.022), triglyceride levels (OR = 1.316, p = 0.031) and decreasing serum glucose levels (OR = 0.933, p = 0.038). Conclusion: The presence or absence of the ACE I/D alleles and genotypes affects the ultimate increase or decrease in the serum glucose, glycated hemoglobin and triglyceride levels. Although there was no significant association between the biomarkers of nephropathy and the ACE I/D alleles or genotypes, the above implicated metabolic indicators should be included in healthcare guidelines used when attending to type 2 diabetic patients. Keywords: angiotensin converting enzyme gene, insertion, deletion, polymorphism, biomarkers, type 2 diabetes mellitus, diabetic nephropathy, Uganda Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes mellitus. 1,2 It is a multifactorial and polygenic disorder that occurs in a quarter to a third of all patients with prolonged diabetes mellitus and has been widely implicated as the leading cause of end-stage renal disease (ESRD). 3 Typically, the disease is diagnosed after significant damage has occurred to the kidney tissue. 4 While DN is known to cause glomerular and tubular basement membrane thickening, and ultimately nephron loss, diagnosis using kidney biopsies are not a common routine practice in resource-limited settings. This creates a pressing need to look for possible early-disease biological markers. A cross-sectional study conducted in adult patients at the diabetic clinic of Mbarara Regional Referral Hospital (MRRH) in southwestern Uganda established a prevalence of diabetic nephropathy at 22.9% among 140 patients who were sampled. 5 Also, evidence from studies has shown that there is clustering of diabetic nephropathy in families, and it is hypothesized that this could be the reason for the observed large variation in its prevalence among diverse populations. 3 In the progression of diabetes mellitus and its complications, one's genetic background is considered to contribute to an inherent susceptibility to diabetic nephropathy. 6 Angiotensin converting enzyme (ACE), a key enzyme in the renin-angioten -Abstract Truncated-
endocrinology & metabolism